Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone in Severe Community-acquired Pneumonia
NCT02552342Phase 4Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- May 2015
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in community acquired pneumonia (CAP) comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: All cause mortality. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT02552342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02552342.